Product Information for the User
Risperdal1mg/ml Oral Solution
risperidone
Read this entire product information carefully before starting to take this medication, as it contains important information for you.
1.What is Risperdal and what is it used for
2.What you need to know before starting to take Risperdal
3.How to take Risperdal
4.Possible adverse effects
5.Storage of Risperdal
6.Contents of the package and additional information
Risperdal belongs to a group of medications known as “antipsychotics”.
Risperdal is used to treat the following:
Risperdal may help reduce the symptoms of your illness and prevent them from returning.
Do not take Risperdal
If you are unsure, consult your doctor or pharmacist before starting to take Risperdal.
Warnings and precautions
Consult your doctor or pharmacist before taking Risperdal if:
If you are unsure about whether the above information affects you, consult your doctor or pharmacist before taking Risperdal.
Because in very rare cases, a dangerously low count of a type of white blood cell necessary to fight infections in the blood has been observed in patients treated with Risperdal, your doctor may check your white blood cell count.
Risperdal may cause you to gain weight. Significant weight gain can negatively affect your health. Your doctor will regularly monitor your weight.
Because diabetes mellitus or worsening of pre-existing diabetes mellitus has been seen in patients taking Risperdal, your doctor should check for signs of elevated blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
Risperdal frequently increases levels of a hormone called prolactin. This can cause adverse effects such as menstrual disorders or fertility problems in women or breast enlargement in men (see Possible Adverse Effects). If these adverse effects appear, it is recommended to evaluate prolactin levels in the blood.
During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not dilate as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery and this may cause eye damage. If you are planning to have eye surgery, be sure to inform your ophthalmologist that you are taking this medication.
Patients with advanced age and dementia
In patients with advanced age and dementia, there is an increased risk of having a stroke. Do not take risperidone if you have dementia caused by a stroke.
During treatment with risperidone, you should see your doctor frequently.
If you or your caregiver notice a sudden change in your mental state or the sudden appearance of weakness or numbness in the face, arms, or legs, especially on one side, or speak confusedly, even for a short time, seek medical treatment immediately. This may be a sign of a stroke.
Children and adolescents
Other causes of aggressive behavior should be ruled out before starting treatment for conduct disorders.
If during treatment with risperidone you experience fatigue, changing the administration times may improve your difficulties in paying attention.
Before starting treatment, your weight or that of your child may be measured, and this should be regularly monitored during treatment.
A small, inconclusive study has reported an increase in the height of children who took risperidone, but it is unknown whether this is due to the medication or another reason.
Other medications and Risperdal
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
It is especially important to talk to your doctor or pharmacist if you are taking any of the following
The following medications may reduce the effect of risperidone
If you start or stop taking these medications, you may need a different dose of risperidone.
The following medications may increase the effect of risperidone
If you start or stop taking these medications, you may need a different dose of risperidone.
If you are unsure about whether the above information affects you, consult your doctor or pharmacist before taking Risperdal.
Use of Risperdal with food, drinks, and alcohol
You can take this medication with or without food. You should avoid consuming alcohol while taking Risperdal.
Pregnancy, breastfeeding, and fertility
Driving and using machines
Dizziness, fatigue, and vision problems have been observed during treatment with Risperdal. Do not drive or operate tools or machines without consulting your doctor first.
Risperdal oral solution contains benzoic acid (E210) and sodium
This medication contains 2 mg of benzoic acid in each 1 ml of oral solution. Benzoic acid may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks old).
This medication contains less than 1 mmol of sodium (23 mg) per dose; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is as follows:
For the treatment of schizophrenia
Adults
Older adults
For the treatment of mania
Adults
Older adults
For the treatment of long-term aggression in people with Alzheimer's disease
Adults (including older adults)
Use in children and adolescents
For the treatment of behavioral disorders
The dose will depend on your child's weight:
If they weigh less than 50 kilograms
If they weigh 50 kilograms or more
The duration of treatment in patients with behavioral disorders should not exceed 6 weeks.
Children under 5 years old should not receive treatment with Risperdal for behavioral disorders.
Patients with kidney or liver problems
Unless the disease being treated is taken into account, all initial doses and subsequent doses of risperidone should be reduced by half. Dose increases should be made more slowly in these patients.
Risperidone should be used with caution in this group of patients.
Administration form
ORAL ROUTE
Risperdal oral solution
The solution comes with a syringe (pipette). You should use it to measure the exact amount of medication you need.
Follow these steps:
1Remove the child-resistant cap. Push the plastic cap down, turning it at the same time against the direction of the clock (Figure 1)
2.Insert the pipette into the bottle (Figure 2)
3.Holding the lower ring, pull the upper ring down to the mark corresponding to the number of milliliters or milligrams you should administer (Figure 3)
4.Holding the lower ring, remove the pipette from the bottle (Figure 4)
5.Empty the pipette into a non-alcoholic drink that is not tea. Slide the upper ring down
6.Close the bottle
7.Wash the pipette with water.
If you take more Risperdal than you should
It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forget to take Risperdal
If you interrupt treatment with Risperdal
You should not stop taking this medication unless your doctor tells you to. Symptoms may reappear.If your doctor decides to stop this treatment, your dose may be gradually reduced over a few days.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Inform your doctor immediately if you experience any of the following rare side effects (which may affect up to 1 in 100 patients):
Inform your doctor immediately if you experience any of the following rare side effects (which may affect up to 1 in 1,000 patients):
You may also experience the following side effects:
Very common side effects (which may affect more than 1 in 10 people):
Common side effects (which may affect up to 1 in 10 people):
Rare side effects (which may affect up to 1 in 100 people):
Rare side effects (which may affect up to 1 in 1,000 people):
Very rare side effects (which may affect up to 1 in 10,000 people):
Unknown frequency: cannot be estimated from available data
The following side effect has appeared with the use of another medication called paliperidone, which is very similar to risperidone, so it is also expected to appear with Risperdal: Fast heartbeat when standing up.
Other side effects in children and adolescents
In general, it is expected that side effects in children will be similar to those that appeared in adults.
The following side effects were reported more frequently in children and adolescents (5 to 17 years) than in adults: feeling drowsy or less attentive, fatigue (tiredness), headache, increased appetite, vomiting, common cold symptoms, nasal congestion, abdominal pain, dizziness, cough, fever, tremor (shaking), diarrhea, urinary incontinence.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet.You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Do not store above30°C.
Do not refrigerate or freeze.
Once the bottle is opened, any unused Risperdal oral solution should be discarded after 3 months.
Medications should not be disposed of through drains or in the trash. Dispose of the containers and medications you no longer need at theSIGREdrop-off point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Risperdal
The active ingredient is risperidone
1 ml of Risperdal oral solution contains 1 milligram of risperidone.
The other components (excipients) are:
Tartaric acid (E334), Benzoic acid (E210), Sodium hydroxide, Distilled water
Appearance of Risperdal and packaging contents
Risperdal oral solution is presented in an amber bottle with a child-resistant cap containing 30 ml, 60 ml, 100 ml, or 120 ml of a transparent and colorless liquid. A dosing pipette is also supplied.
The pipette supplied with the 30 ml, 60 ml, and 100 ml bottles is graduated in milligrams and milliliters with a minimum volume of 0.25 ml and a maximum volume of 3 ml. The graduation marks in increments of 0.25 ml (equivalent to 0.25 mg of oral solution) to 3 ml (equivalent to 3 mg of oral solution) are printed on this pipette.
The pipette supplied with the 120 ml bottle is graduated in milligrams and milliliters with a minimum volume of 0.25 ml and a maximum volume of 4 ml. The graduation marks of 0.25 ml (equivalent to 0.25 mg of oral solution) that increase to 4 ml (equivalent to 4 mg of oral solution) are printed on this pipette.
Only some packaging sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
JANSSEN-CILAG, S.A.
Paseo de Las Doce Estrellas, 5-7
28042 Madrid, Spain
+34 917228100
+34 917228101
Responsible for batch release
JANSSEN PHARMACEUTICA NV
Turnhoutseweg, 30 (Beerse) – B-2340 – Belgium.
Lusomedicamenta Sociedade Técnica Farmacêutica S.A.
Estrada Consiglieri Pedroso 66, 69-B
Queluz de Baixo
2730-055 Barcarena
Portugal
This medicine is authorized in the member states of the European Economic Areaand in the United Kingdom (Northern Ireland)with the following names:
Austria:Risperdal
Bélgica: RISPERDAL
Chipre:RISPERDAL
República Checa:RISPERDAL
Dinamarca: RISPERDAL
Estonia:RISPOLEPT
Finlandia:RISPERDAL
Francia:RISPERDAL
Alemania:RISPERDAL1mg; 2mg; 3mg; 4mg/ Risperdal 0,5mg; 6mg / Risperdal Lösung 1 mg/ml
Grecia:RISPERDAL
Hungría:RISPERDAL
Islandia:RISPERDAL
Irlanda:RISPERDAL
Italia:RISPERDAL
Lituania:RISPOLEPT
Letonia:RISPOLEPT
Luxemburgo:RISPERDAL
Malta:RISPERDAL
Países Bajos:RISPERDAL
Noruega:RISPERDAL
Polonia:RISPOLEPT
Portugal:RISPERDAL
Rumanía:RISPOLEPT
Eslovenia:RISPERDAL
España:RISPERDAL
Suecia:RISPERDAL
Reino Unido(Irlanda del Norte):RISPERDAL
Last revision date of this leaflet:April 2025.
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es).
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.